This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...
GlobalData on MSN3d
JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year aheadAstraZeneca says a strong 2024 and stacked pipeline spells potential for further growth in 2025 as the company aims to bring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback